Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

Mina Hah, Kiki Chang

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.

Original languageEnglish (US)
Pages (from-to)996-1004
Number of pages9
JournalJournal of Child and Adolescent Psychopharmacology
Volume15
Issue number6
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Bipolar Disorder
Pediatrics
Therapeutics
Appetite
Nausea
Outpatients
Atomoxetine Hydrochloride
Incidence

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. / Hah, Mina; Chang, Kiki.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 15, No. 6, 12.2005, p. 996-1004.

Research output: Contribution to journalArticle

@article{de5afc2b763641e29aa127c2f4094d7b,
title = "Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders",
abstract = "Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.",
author = "Mina Hah and Kiki Chang",
year = "2005",
month = "12",
doi = "10.1089/cap.2005.15.996",
language = "English (US)",
volume = "15",
pages = "996--1004",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

AU - Hah, Mina

AU - Chang, Kiki

PY - 2005/12

Y1 - 2005/12

N2 - Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.

AB - Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.

UR - http://www.scopus.com/inward/record.url?scp=29944443819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29944443819&partnerID=8YFLogxK

U2 - 10.1089/cap.2005.15.996

DO - 10.1089/cap.2005.15.996

M3 - Article

C2 - 16379520

AN - SCOPUS:29944443819

VL - 15

SP - 996

EP - 1004

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 6

ER -